Conjugates of salicylaldoximes and peripheral site ligands: Novel efficient nonquaternary reactivators for nerve agent-inhibited acetylcholinesterase

被引:22
|
作者
Wei, Zhao [1 ]
Liu, Yan-qin [2 ]
Wang, Sheng-zheng [1 ]
Yao, Lin [1 ]
Nie, Hui-fang [1 ]
Wang, Yong-an [2 ]
Liu, Xue-ying [1 ]
Zheng, Zhi-bing [3 ]
Li, Song [3 ]
机构
[1] Fourth Mil Med Univ, Sch Pharm, Dept Med Chem, Xian 300071, Shaanxi, Peoples R China
[2] Acad Mil Med Sci, Inst Pharmacol & Toxicol, Dept Mil Toxicol & Biochem Pharmacol, Beijing 100850, Peoples R China
[3] Acad Mil Med Sci, Inst Pharmacol & Toxicol, Dept Med Chem, Beijing 100850, Peoples R China
关键词
Nerve agent; Human acetylcholinesterase; Nonquaternary reactivator; Salicylaldoxime conjugates; Peripheral site ligand; BLOOD-BRAIN-BARRIER; ORGANOPHOSPHORUS COMPOUNDS; UNCHARGED REACTIVATORS; PYRIDINIUM OXIMES; ADMET PREDICTION; CLICK CHEMISTRY; IN-SITU; CHOLINESTERASES; SARIN; ALDOXIME;
D O I
10.1016/j.bmc.2017.06.041
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A new family of nonquaternary reactivators for nerve agent-inhibited human acetylcholinesterase (hAChE) were designed, synthesized and tested in this paper. It was found that salicylaldoximes were able to quickly cleave the P-S bond of organophosphate and avoid the reinhibition phenomenon in the reactivation process, but they lacked reactivating ability due to poor affinity for AChE. Based on a dual site binding strategy, different peripheral site ligands of AChE were introduced to achieve extra affinity. The in vitro reactivation experiments demonstrated that some of the yielding conjugates exhibited similar or even superior ability to reactivate sarin-, VX- or tabun-inhibited hAChE in comparison with the mono-and bis-pyridinium aldoximes currently used. Moreover, due to greatly improved lipophilicity, these nonquaternary conjugates hold promise for the development of efficient centrally activating reactivators. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4497 / 4505
页数:9
相关论文
共 37 条
  • [31] Reactivation of nerve agent-inhibited human acetylcholinesterase by obidoxime, HI-6 and obidoxime+HI-6: Kinetic in vitro study with simulated nerve agent toxicokinetics and oxime pharmacokinetics
    Worek, Franz
    Koller, Marianne
    Thiermann, Horst
    Wille, Timo
    TOXICOLOGY, 2016, 350 : 25 - 30
  • [32] Synthesis and in vitro evaluation of novel non-oximes for the reactivation of nerve agent inhibited human acetylcholinesterase
    de Koning, Martijn C.
    Horn, Gabriele
    Worek, Franz
    van Grol, Marco
    CHEMICO-BIOLOGICAL INTERACTIONS, 2020, 326
  • [33] 6-Methyluracil derivatives as peripheral site ligand-hydroxamic acid conjugates: Reactivation for paraoxon-inhibited acetylcholinesterase
    Semenov, Vyacheslav E.
    Zueva, Irina V.
    Lushchekina, Sofya V.
    Lenina, Oksana A.
    Gubaidullina, Lilya M.
    Saifina, Lilya F.
    Shulaeva, Marina M.
    Kayumova, Ramilya M.
    Saifina, Alina F.
    Gubaidullin, Aidar T.
    Kondrashova, Svetlana A.
    Latypov, Shamil K.
    Masson, Patrick
    Petrov, Konstantin A.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 185
  • [34] In vitro reactivation potency of novel symmetrical bis-pyridinium oximes for electric eel acetylcholinesterase inhibited by nerve agent sarin
    Acharya, Jyotiranjan
    Dubey, Devendra Kumar
    Kaushik, M. P.
    TOXICOLOGY IN VITRO, 2011, 25 (08) : 2135 - 2139
  • [35] Oxime K027: novel low-toxic candidate for the universal reactivator of nerve agent- and pesticide-inhibited acetylcholinesterase
    Kuca, Kamil
    Musilek, Kamil
    Jun, Daniel
    Pohanka, Miroslav
    Ghosh, Kallol Kumar
    Hrabinova, Martina
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2010, 25 (04) : 509 - 512
  • [36] In vitro potency of H oximes (HI-6, HLo-7), the oxime BI-6, and currently used oximes (pralidoxime, obidoxime, trimedoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase
    Kuca, Kamil
    Cabal, Jiri
    Kassa, Jiri
    Jun, Daniel
    Hrabinova, Martina
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2006, 69 (15): : 1431 - 1440
  • [37] A comparison of the ability of a new bispyridinium oxime-1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium)butane dibromide and currently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods
    Kuca, K
    Kassa, J
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2003, 18 (06) : 529 - 535